Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Payne

Showing results (321-330 of 393) with videos related to

Pageof 40
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1994
Hospital admissions and social deprivation of patients with diabetes mellitusS L Caddick, M McKinnon, N Payne, et al.
Lancet (London, England)|August 10, 1996
Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield tableL E Ramsay, I U Haq, P R Jackson, et al.
Fertility and Sterility|October 31, 1998
Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovariesR Agrawal, G Conway, P Sladkevicius, et al.
Optics Letters|October 29, 2009
Femtosecond pulse amplification in cladding-pumped fibersJ D Minelly, A Galvanauskas, M E Fermann, et al.
Avian Pathology : Journal of the W.V.P.A|April 1, 1984
Marek's disease in turkeys: the induction of lesions and the establishment of lymphoid cell linesP C Powell, K Howes, A M Lawn, et al.
Optics Express|June 18, 2009
Efficient white light generation in secondary cores of holey fibersP Dupriez, F Poletti, P Horak, et al.
International Journal of Nanomedicine|April 12, 2018
Development of dihydrochalcone-functionalized gold nanoparticles for augmented antineoplastic activityJason N Payne, Vivek D Badwaik, Hitesh K Waghwani, et al.
Public Health|August 24, 2015
The return of public health to local government in England: changing the parameters of the public health prioritization debate?L Marks, D J Hunter, S Scalabrini, et al.
Heart (British Cardiac Society)|August 24, 1999
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatmentD M Pickin, C J McCabe, L E Ramsay, et al.
Clinical Endocrinology|May 26, 1999
Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: association with changes in ovarian and uterine Doppler blood flowR Agrawal, G S Conway, P Sladkevicius, et al.
Pageof 40

Showing results (321-330 of 393) with videos related to

Sort By:
Pageof 40
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1994
Hospital admissions and social deprivation of patients with diabetes mellitusS L Caddick, M McKinnon, N Payne, et al.
Lancet (London, England)|August 10, 1996
Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield tableL E Ramsay, I U Haq, P R Jackson, et al.
Fertility and Sterility|October 31, 1998
Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovariesR Agrawal, G Conway, P Sladkevicius, et al.
Optics Letters|October 29, 2009
Femtosecond pulse amplification in cladding-pumped fibersJ D Minelly, A Galvanauskas, M E Fermann, et al.
Avian Pathology : Journal of the W.V.P.A|April 1, 1984
Marek's disease in turkeys: the induction of lesions and the establishment of lymphoid cell linesP C Powell, K Howes, A M Lawn, et al.
Optics Express|June 18, 2009
Efficient white light generation in secondary cores of holey fibersP Dupriez, F Poletti, P Horak, et al.
International Journal of Nanomedicine|April 12, 2018
Development of dihydrochalcone-functionalized gold nanoparticles for augmented antineoplastic activityJason N Payne, Vivek D Badwaik, Hitesh K Waghwani, et al.
Public Health|August 24, 2015
The return of public health to local government in England: changing the parameters of the public health prioritization debate?L Marks, D J Hunter, S Scalabrini, et al.
Heart (British Cardiac Society)|August 24, 1999
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatmentD M Pickin, C J McCabe, L E Ramsay, et al.
Clinical Endocrinology|May 26, 1999
Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: association with changes in ovarian and uterine Doppler blood flowR Agrawal, G S Conway, P Sladkevicius, et al.
Pageof 40